Edition:
United Kingdom

Clovis Oncology Inc (CLVS.OQ)

CLVS.OQ on NASDAQ Stock Exchange Global Select Market

26.36USD
19 Oct 2018
Change (% chg)

$-3.60 (-12.02%)
Prev Close
$29.96
Open
$30.55
Day's High
$30.75
Day's Low
$26.13
Volume
1,599,333
Avg. Vol
353,329
52-wk High
$79.36
52-wk Low
$26.13

Select another date:

Tue, Sep 18 2018

Clovis Oncology, execs to pay $20 million to settle SEC charges

WASHINGTON U.S. biotechnology company Clovis Oncology Inc and its Chief Executive Patrick Mahaffy and former CFO Erle Mast, will pay more than $20 million to settle charges of misleading investors about the efficacy of a cancer drug, the top U.S. securities regulator said on Tuesday.

Clovis Oncology, execs to pay $20 million to settle SEC charges

WASHINGTON, Sept 18 U.S. biotechnology company Clovis Oncology Inc and its Chief Executive Patrick Mahaffy and former CFO Erle Mast, will pay more than $20 million to settle charges of misleading investors about the efficacy of a cancer drug, the top U.S. securities regulator said on Tuesday.

BRIEF-Clovis Oncology Reports Q1 Loss Per Share $1.54

* CLOVIS ONCOLOGY ANNOUNCES FIRST QUARTER 2018 OPERATING RESULTS

BRIEF-Clovis Oncology CEO Patrick Mahaffy's 2017 Total Compensation Was $8.7 Million

* CLOVIS ONCOLOGY INC SAYS CEO PATRICK MAHAFFY'S 2017 TOTAL COMPENSATION WAS $8.7 MILLION – SEC FILING Source text for Eikon: (http://bit.ly/2KnbE4y) Further company coverage:

Select another date: